Vienna, Austria – November 2025
TAmiRNA proudly announces the release of its miND® spike-in kit in a new lyophilized format, optimized for the preparation and analysis of 96 small RNA-sequencing libraries. This upgraded format improves handling, stability, and integration with standard small RNA-sequencing workflows, ensuring seamless compatibility with commonly used library preparation kits.
The new lyophilized miND® spike-in kit combines ease of use and long-term stability with TAmiRNA’s proven spike-in design (5’ and 3’ end randomization) for accurate and reproducible normalization in small RNA-sequencing experiments. The revised 96-reaction format is ideal for medium- to large-scale studies and simplifies quality control across multiple runs.
In addition, TAmiRNA has generated new data confirming the robust performance and stability of miND® spike-ins across a broad range of sample types, including challenging materials such as liquid biopsies, cell culture secretomes, and extracellular vesicles. These results underscore the unique value of miND® spike-ins as a universal quality control tool for assessing technical performance and data reproducibility in small RNA-sequencing experiments.
The dynamic range of the miND® spike-ins has been carefully optimized to support absolute quantification of microRNA copies, independent of the RNA composition of the input sample. This enables researchers to achieve consistent, quantitative insight into microRNA abundance, improving the reliability of biomarker discovery and validation studies.
With this latest innovation, TAmiRNA continues its mission to provide high-quality tools that empower scientists to explore the small RNA landscape with confidence and precision.
For more information about the miND® spike-in kit, visit https://www.tamirna.com/mind-spike-in-controls-for-small-rna-sequencing-tamirna/
Leave A Comment
You must be logged in to post a comment.